Molecular Decoys: Ligand-binding Recombinant Proteins Protect Mice from Curarimimetic Neurotoxins
Overview
Authors
Affiliations
Mimic ligand-binding sites of the nicotinic acetylcholine receptor bind d-tubocurarine and alpha-bungarotoxin in vitro. Injection of such binding sites into mice could act as molecular decoys in vivo, providing protection against toxic ligands. This hypothesis of molecular "decoyance" has been tested in greater than 250 mice. Bacterially produced cholinergic binding sites provided a 2-fold increase in the survival rate of animals challenged with curarimimetic neurotoxins. Possible considerations for decoy designs and their applications are discussed.
Rational design of universal immunotherapy for TfR1-tropic arenaviruses.
Cohen-Dvashi H, Amon R, Agans K, Cross R, Borenstein-Katz A, Mateo M Nat Commun. 2020; 11(1):67.
PMID: 31900422 PMC: 6941993. DOI: 10.1038/s41467-019-13924-6.
Robertson S, Smedley 3rd J, McClane B Infect Immun. 2009; 78(1):505-17.
PMID: 19884339 PMC: 2798200. DOI: 10.1128/IAI.00778-09.
Molecular decoys: antidotes, therapeutics and immunomodulators.
Gershoni J Curr Opin Biotechnol. 2008; 19(6):644-51.
PMID: 18977299 PMC: 7127390. DOI: 10.1016/j.copbio.2008.10.001.
Neurobiology. Snails, synapses and smokers.
Dougherty D, Lester H Nature. 2001; 411(6835):252-3, 255.
PMID: 11357112 DOI: 10.1038/35077192.